Actelion

26 results

Johnson & Johnson reported slightly better-than-expected quarterly profit on Tuesday, helped by demand for its cancer drugs. Photograph: Mike Blake/Reuters

Johnson & Johnson reported slightly better-than-expected quarterly profit on Tuesday and pushed its full-year forecast higher, as demand for its c(...)

Pharma giant Johnson & Johnson reported a higher-than-expected quarterly profit and raised its full-year forecast

Pharma giant Johnson & Johnson reported a higher-than-expected quarterly profit and raised its full-year forecast, driven by strong demand for its(...)

Sales in Johnson & Johnson’s consumer and medical device divisions rose despite a negative currency impact but  demand for pharmaceutical products – its largest business – fell marginally. Photograph: Mike Blake / Reuters

Johnson & Johnson raised its full-year profit forecast and reported better-than-expected quarterly earnings on Tuesday, helped by strong demand f(...)

Unilever products. Shares in the Marmite, Dove soap and PG Tips firm were down 157.5 pence to 3,191 pence at the close

European shares held around one-year highs on Thursday, supported by mergers and acquisitions-related optimism, with Johnson & Johnson’s $30 billi(...)

JandJ, already the world’s biggest maker of healthcare products, is fulfilling its goal of adding a new drug category

Johnson and Johnson (JandJ) has agreed to buy Actelion for $30 billion (€28.1bn), clinching one of its largest ever deals to become a leader in medici(...)

Under the proposed deal  Actelion shareholders could  benefit further financially from Actelion’s R&D pipeline. Photograph: Reuters

Johnson & Johnson is negotiating a deal to acquire Swiss biotechnology company Actelion Ltd that would separate Actelion’s commercialised portfoli(...)

US stocks slipped in light trading on Thursday ahead of the holiday season. Photograph: Andrew Kelly/Reuters

European stocks inched lower amid thin trading, with investors signalling reluctance to extend a rally as the last full trading week of 2016 unfolded.(...)

The headquarters of Swiss biotech company Actelion in Allschwil, Switzerland. Photograph: Arnd Wiegmann/File Photo/Reuters

In a surprise twist to one of 2016’s biggest potential health deals, Actelion and US drug giant Johnson and Johnson are back at the negotiating table (...)

The headquarters of Swiss biotech company Actelion in Allschwil, Switzerland. Photograph: Arnd Wiegmann/Reuters

Swiss biotech group Actelion’s shares rose by more than 3 per cent on Wednesday following a report that talks with Sanofi are making progress, increas(...)

Ryanair put in another strong session, rising 1.7 per cent, following sector wide trends. Photograph: Nick Ansell/PA Wire

European stocks climbed to an 11-month high on merger and acquisition speculation on Friday, while the dollar’s rally paused as investors adjusted the(...)

  • 1
  • 2
  • 3
  • Next
  • Last »